Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00792246 · ClinicalTrials.gov registry record · Phase 1
Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
A Phase 1 study, sponsored by Phillip Brian Smith.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT00792246: Completed Phase 1 study, sponsored by Phillip Brian Smith.
NCT00792246 is a Phase 1 study that has completed, run by Phillip Brian Smith. The registered enrollment target is 5 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00792246, a Phase 1 study, has completed, sponsored by Phillip Brian Smith.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
Determine how much voriconazole is absorbed when the product is given by mouth to children with extensive graft versus host disease after a stem cell transplantation and determine the correct dosing of voriconazole in this population. Hypothesis: Children with gastrointestinal graft versus host disease will have decreased absorption of oral voriconazole and require higher doses of voriconazole in order to prevent or treat fungal infections.
Interventions
- DRUG voriconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-07 |
| Phase | Phase 1 |
What the finished NCT00792246 record still lists
NCT00792246 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which voriconazole is the first listed.
NCT00792246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00792246 about?
NCT00792246 is a clinical study titled "Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease". Determine how much voriconazole is absorbed when the product is given by mouth to children with extensive graft versus host disease after a stem cell transplantation and determine the correct dosing of voriconazole in this population. Hypothesis: Children with gastrointestinal graft versus host dis...
What is the current status of trial NCT00792246?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2008-12. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00792246?
The interventions under investigation include: voriconazole (DRUG).
Who is sponsoring clinical trial NCT00792246?
This trial is sponsored by Phillip Brian Smith, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00792246's enrollment target sits among peer trials
5 1989th of 2000 higher than 6 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia